Molecular profiling for precision cancer therapies von Malone, Eoghan R., Oliva, Marc, Sabatini, Peter J. B., Stockley, Tracy L., Siu, Lillian L.

Volltext

Circulating tumor DNA and liquid biopsy in oncology von Cescon, David W., Bratman, Scott, Chan, Steven M., Siu, Lillian L.

Volltext

Dose Escalation Methods in Phase I Cancer Clinical Trials von Le Tourneau, Christophe, Lee, J. Jack, Siu, Lillian L.

Volltext

Designing Transformative Clinical Trials in the Cancer Genome Era von Sleijfer, Stefan, Bogaerts, Jan, Siu, Lillian L

Volltext

Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment von Brana, Irene, Siu, Lillian L

Volltext

Approaches to modernize the combination drug development paradigm von Day, Daphne, Siu, Lillian L

Volltext

Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline von Nekhlyudov, Larissa, Lacchetti, Christina, Davis, Nancy B, Garvey, Thomas Q, Goldstein, David P, Nunnink, J Chris, Ninfea, Jose I Ruades, Salner, Andrew L, Salz, Talya, Siu, Lillian L

Volltext

Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis von O'Sullivan, Brian, Huang, Shao Hui, Siu, Lillian L, Waldron, John, Zhao, Helen, Perez-Ordonez, Bayardo, Weinreb, Ilan, Kim, John, Ringash, Jolie, Bayley, Andrew, Dawson, Laura A, Hope, Andrew, Cho, John, Irish, Jonathan, Gilbert, Ralph, Gullane, Patrick, Hui, Angela, Liu, Fei-Fei, Chen, Eric, Xu, Wei

Volltext

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study von Harrington, Kevin J., Kong, Anthony, Mach, Nicolas, Chesney, Jason A., Fernandez, Beatriz Castelo, Rischin, Danny, Cohen, Ezra E. W., Radcliffe, Hoi-Shen, Gumuscu, Burak, Cheng, Jonathan, Snyder, Wendy, Siu, Lillian L.

Volltext

Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era von Araujo, Daniel V., Oliva, Marc, Li, Kecheng, Fazelzad, Rouhi, Liu, Zhihui Amy, Siu, Lillian L.

Volltext

Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway von BUSAIDY, Naifa L, FAROOKI, Azeez, DOWLATI, Afshin, PERENTESIS, John P, DANCEY, Janet E, DOYLE, Laurence A, BRELL, Joanna M, SIU, Lillian L

Volltext

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy von Cunningham, Morven, Iafolla, Marco, Kanjanapan, Yada, Cerocchi, Orlando, Butler, Marcus, Siu, Lillian L., Bedard, Philippe L., Ross, Kendra, Hansen, Bettina, Spreafico, Anna, Feld, Jordan J.

Volltext

Tumor-Naive Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma von Burgener, Justin M., Zou, Jinfeng, Zhao, Zhen, Zheng, Yangqiao, Shen, Shu Yi, Huang, Shao Hui, Keshavarzi, Sareh, Xu, Wei, Liu, Fei-Fei, Liu, Geoffrey, Waldron, John N., Weinreb, Ilan, Spreafico, Anna, Siu, Lillian L., de Almeida, John R., Goldstein, David P., Hoffman, Michael M., De Carvalho, Daniel D., Bratman, Scott V.

Volltext

First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting von Molckovsky, Andrea, Siu, Lillian L

Volltext

Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials von Veitch, Zachary W, Shepshelovich, Daniel, Gallagher, Christina, Wang, Lisa, Abdul Razak, Albiruni R, Spreafico, Anna, Bedard, Philippe L, Siu, Lillian L, Minasian, Lori, Hansen, Aaron R

Volltext

Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials von Gadalla, Ramy, Noamani, Babak, MacLeod, Bethany L, Dickson, Russell J, Guo, Mengdi, Xu, Wenxi, Lukhele, Sabelo, Elsaesser, Heidi J, Razak, Albiruni R Abdul, Hirano, Naoto, McGaha, Tracy L, Wang, Ben, Butler, Marcus, Guidos, Cynthia J, Ohashi, Pam S, Siu, Lillian L, Brooks, David G

Volltext

Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis von Yan, Marie, Kumachev, Alexander, Siu, Lillian L, Chan, Kelvin K.W

Volltext

Using real-word data to evaluate the effects of broadening eligibility criteria in oncology trials von Sanz-Garcia, Enrique, Haibe-Kains, Benjamin, Siu, Lillian L.

Volltext

Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials von TOWNSLEY, Carol A, SELBY, Rita, SIU, Lillian L

Volltext

Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion von Adelstein, David J, Ismaila, Nofisat, Ku, Jamie A, Burtness, Barbara, Swiecicki, Paul L, Mell, Loren, Beitler, Jonathan J, Gross, Neil, Jones, Christopher U, Kaufman, Marnie, Le, Quynh-Thu, Semrad, Thomas J, Siu, Lillian L, Ridge, John A

Volltext